Accera's Series B Round

Accera raised a round of funding on August 24, 2006.

Accera is a biopharmaceutical company with a drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of therapeutic drugs and medical foods for neurodegenerative diseases such …

Articles about Accera's Series B Round: